07 Aug, 2026 - By CMI | Biotechnology
Alteogen Signs An Exclusive Agreement With A Global Pharmaceutical Company To Develop And Commercialize A Hybrozyme-Based Subcutaneous Biologic Medicine
Alteogen Inc., a South Korean biopharmaceutical company, has signed an exclusive agreement with a global pharmaceutical company to develop as well as ...
View more
